Skip to main content
锦波生物 logo

锦波生物 — Investor Relations & Filings

Ticker · 920982 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2023-10-25 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920982

About 锦波生物

https://www.sxjbswyy.com/

Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of functional proteins through synthetic biology. The company is recognized for its industrialization of recombinant humanized collagen, specifically Type III collagen with a stable triple helix structure. Its core business encompasses the production of medical-grade biomaterials, functional skincare products, and medical devices used in aesthetics, wound healing, and gynecological health. By utilizing advanced protein engineering, the company provides biocompatible solutions designed for tissue repair and anti-aging applications. Its technical focus remains on the structural optimization and large-scale production of high-purity recombinant proteins to meet clinical and consumer health demands.

Recent filings

Filing Released Lang Actions
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "山西锦波生物医药股份有限公司 2023 年第三季度报告" which translates to "Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. 2023 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes for the period ending September 30, 2023. The document explicitly states it is a quarterly report and includes comprehensive financial statements and management commentary. It is not an announcement or a brief summary but a full financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-25 Chinese
对外担保制度
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by the company's board. It details the company's internal policies and procedures regarding external guarantees, including approval processes, risk management, disclosure, and responsibilities. It is a governance-related document outlining internal rules and management practices rather than a financial report, announcement, or regulatory filing. There is no indication that this is an announcement of a report or a certification. The document is substantive and detailed, focusing on governance and internal control policies. Therefore, the most appropriate classification is Governance Information (CGR).
2023-10-25 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled "关联交易管理制度" which translates to "Related Party Transaction Management System." It is a detailed policy document outlining the principles, procedures, and disclosure requirements for related party transactions within the company. It includes sections on definitions, pricing, approval processes by the board and shareholders, disclosure obligations, and exemptions. The document is issued by the company's board and dated October 26, 2023. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for managing related party transactions, which falls under governance information rather than regulatory filings or other categories. Therefore, the most appropriate classification is Governance Information (CGR).
2023-10-25 Chinese
董事会审计委员会议事规则
Governance Information Classification · 95% confidence The document is titled "董事会审计委员会议事规则" which translates to "Board Audit Committee Meeting Rules." It details the rules, responsibilities, composition, meeting procedures, and duties of the audit committee under the board of directors. The content is focused on governance, internal control, audit oversight, and committee operations rather than financial results or audit opinions. There is no indication of financial statements, audit reports, or regulatory filings of financial data. The document is a governance-related internal rules document for the audit committee, which fits the definition of Governance Information (CGR). The document length is sufficient and it is not a brief announcement or certification, so it is not RNS or RPA. Therefore, the best classification is Governance Information (CGR).
2023-10-25 Chinese
监事辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a supervisory board member (监事) of the company. It details the resignation date, reasons, impact on the board composition, and legal compliance. There is no financial data, no mention of financial results, no report publication, or regulatory certification. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-10-09 Chinese
关于更换持续督导保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of continuous supervision sponsor representatives for a company listed on the Beijing Stock Exchange. It details personnel changes in the sponsor representatives and includes a brief resume of the new representative. There is no financial data, no report attached or referenced as being published, and no mention of voting results or other report types. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about management/sponsor changes but not a direct management or board change announcement (which would be MANG).
2023-09-26 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.